Company: SISI
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001493152-25-006895
Chunk: 185

Company: SHINECO, INC.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 2
Chunk 185
---
 operations 
     (4,847,811) 
     (8,569,226) 
     3,721,415  
     (43.43)%
  
    Net income from discontinued operations 
     -  
     8,855,247  
     (8,855,247) 
     (100.00)%
  
    Net income (loss) 
    $(4,847,811) 
    $286,021  
    $(5,133,832) 
     (1,794.91)%
  
    Comprehensive income (loss) attributable to Shineco Inc. 
    $(3,660,423) 
    $1,167,709  
    $(4,828,132) 
     (413.47)%

Revenue

Currently,
we, through our PRC subsidiaries, have three major business segments from continuing operations. First, developing, producing and distributing
innovative rapid diagnostic and other products and related medical devices for the most common diseases; this segment is conducted through
Biowin. Second, producing, processing and distributing silk products, and providing fruit trading business; this segment is conducted
through Wintus. Third, developing and selling healthy meals for people with slow metabolic health and those in recovery from metabolic
disorders; this segment is conducted through Fuzhou Meida.

The
following table sets forth the breakdown of our revenue for the six months ended December 31, 2024 and 2023, respectively:

    Six Months Ended December 31,  
    Variance 

    2024  
    %  
    2023  
    %  
    Amount  
    % 
  
    Rapid diagnostic and other products 
    $217,120  
     4.15% 
    $299,122  
     7.57% 
    $(82,002) 
     (27.41)%
  
    Other agricultural products 
     5,005,387  
     95.83% 
     3,642,533  
     92.15% 
     1,362,854  
     37.42%
  
    Healthy meal products 
     949  
     0.02% 
     11,104  
     0.28% 
     (10,155) 
     (91.45)%